Item 7.01 Regulation FD Disclosure.

On January 8, 2021, Chimerix, Inc. (the "Company") will post a corporate presentation on its website concerning its acquisition of Oncoceutics, Inc. (the "Acquisition"). A copy of the presentation is furnished herewith as Exhibit 99.1 to this Current Report on Form 8-K.

On January 8, 2021, the Company issued a press release announcing the Acquisition. A copy of the press release is filed as Exhibit 99.2 to this Current Report on Form 8-K, the contents of which are incorporated herein by reference.

The information contained in this Item 7.01 and in Exhibits 99.1 and 99.2 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and is not incorporated by reference into any of the Company's filings under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, except as shall be expressly set forth by specific reference in any such filing.





 Item 9.01 Exhibits.




(d) Exhibits



 Exhibit
 Number                              Exhibit Description
  99.1        Corporate Presentation

  99.2        Press Release dated January 8, 2021

104         Cover page interactive data file (embedded within the iXBRL document)

© Edgar Online, source Glimpses